Delivery Order SPE2DB22D2009-SPE2DB24FL9QW

Award Date 5/11/24
Potential Completion Date 5/13/24
Potential Value $9K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,716.57, is a delivery order under the company's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to...
This federal contract award, valued at $20,450.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, and has an ultimate completion date of April 26, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major...
This federal contract award, valued at $3,671.71, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has an ultimate completion date of December 6, 2023 and is a firm fixed-price delivery order. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,303.97 firm-fixed-price delivery order is for MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $6,029.85, is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 9, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,450.57 delivery order is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a prescription medication. The contract is a firm fixed-price delivery order with a completion date of November 8, 2023. This award is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $25,152.10, is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an Ultimate Completion Date of November 8, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract, with a ceiling value of $1,756.32, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by the company with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00. The DLA, a defense agency, is the primary funding agency for this award, which does not...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $17,641.70 firm fixed-price delivery order is for the supply of the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.8ML. The contract has an ultimate completion date of September 28, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,289.22, is for the delivery of MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of January 4, 2024 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB24FL9QW
    Delivery Order

This federal contract award, valued at $9,025.66, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of May 13, 2024. The contract is a delivery order and is priced on a firm fixed-price basis. This award is not associated with any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.

Generated 5/16/25, 12:27 PM